Anixa Biosciences (ANIX) Enterprise Value (2011 - 2026)
Anixa Biosciences (ANIX) posted Enterprise Value of $103.15 million for fiscal Q3 2026 (quarter ended Jul 31, 2026), up 23.9% from $83.22 million a year earlier and up 18.8% from the prior quarter.
Powered by 
Analysis
Anixa Biosciences (ANIX) Enterprise Value (2011 - 2026) Analysis & Trends
For FY2025 (ended Oct 31, 2025), Anixa Biosciences' Enterprise Value came in at $119.96 million, up 30.9% from FY2024.
- Annual Enterprise Value shows a five-year compound annual growth rate of 24.3% (FY2020 to FY2025).
- In prior fiscal years, Anixa Biosciences' Enterprise Value was $91.66 million in FY2024 (+24.5%), $73.61 million in FY2023 (-46.6%), $137.75 million in FY2022 (+28.8%) and $106.94 million in FY2021 (+164.7%).
- Quarterly Enterprise Value has run from a low of $63.32 million in fiscal Q1 2022 to a high of $141.13 million in fiscal Q4 2022 over five years.
- On a year-over-year basis, Enterprise Value increased in five of the last seven quarters, with growth averaging 8.9%.
- The strongest year-over-year quarter for Enterprise Value in the past five years was fiscal Q4 2021, with growth of 164.7%; the weakest was fiscal Q4 2023, with a decline of 47.8%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Anixa Biosciences | 101.33 Mn | 100.06 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 103.15 Mn |
| Apr 30, 2026 | 86.83 Mn |
| Oct 31, 2025 | 119.96 Mn |
| Jul 31, 2025 | 83.22 Mn |
| Apr 30, 2025 | 73.11 Mn |
| Jan 31, 2025 | 74.98 Mn |
| Oct 31, 2024 | 91.66 Mn |
| Jul 31, 2024 | 84.90 Mn |
| Apr 30, 2024 | 70.78 Mn |
| Jan 31, 2024 | 119.37 Mn |
| Oct 31, 2023 | 73.61 Mn |
| Jul 31, 2023 | 84.88 Mn |
| Apr 30, 2023 | 98.44 Mn |
| Jan 31, 2023 | 105.37 Mn |
| Oct 31, 2022 | 141.13 Mn |
| Jul 31, 2022 | 84.02 Mn |
| Apr 30, 2022 | 64.67 Mn |
| Jan 31, 2022 | 63.32 Mn |
| Oct 31, 2021 | 106.94 Mn |
| Jul 31, 2021 | 95.14 Mn |
API Access
Anixa Biosciences Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=ANIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "ANIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=ANIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();